Hepln-13 T25492
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Hepln-13 is a hepsin inhibitor that acts by hindering prostate cancer bone metastasis.
CAS nr:
64369-13-7
Purity:
98%
Molecular Weight:
325,2
SMILES:
Brc1ccc(C(N2)Nc3cccc4cccc2c34)cc1
Formula:
C17H13BrN2
Pathway:
Tyrosine Kinase/Adaptors
Target:
c-Met/HGFR
